Carboplatin-gemcitabine combination chemotherapy upregulates AKR1B10 expression in bladder cancer

International Journal of Clinical Oncology

Volumn 18, Issue 1, 2013, Pages 177-182

  Hashimoto, Yasuhiro ^a   Imanishi, Kengo ^a   Tokui, Noriko ^a   Okamoto, Teppei ^a   Okamoto, Akiko ^a   Hatakeyama, Shingo ^a   Yoneyama, Takahiro ^a   Koie, Takuya ^a   Kamimura, Noritaka ^a   Ohyama, Chikara ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

AKR1B10; Bladder cancer; Carboplatin gemcitabine combination chemotherapy; Recurrence after chemotherapy

Indexed keywords

CARBOPLATIN; GEMCITABINE; MESSENGER RNA;

ADULT; AGED; AKR1B10 GENE; ARTICLE; BLADDER BIOPSY; BLADDER CANCER; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; COMBINATION CHEMOTHERAPY; CYSTECTOMY; DISEASE FREE SURVIVAL; FEMALE; GENE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCORING SYSTEM; SURVIVAL RATE; SURVIVAL TIME;

AGED; AGED, 80 AND OVER; ALDEHYDE REDUCTASE; CARBOPLATIN; CYSTECTOMY; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; DRUG THERAPY, COMBINATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; URINARY BLADDER NEOPLASMS;

EID: 84874111708     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-011-0363-7     Document Type: Article

References (19)

1. Penning TM (2005) AKR1B10: a new diagnostic marker of non-small cell lung carcinoma in smokers. Clin Cancer Res 11:1687-1690
2. Kasajima H, Yamagishi S, Sugai S et al (2001) Enhanced in situ expression of aldose reductase in peripheral nerve and renal glomeruli in diabetic patients. Virchows Arch 439:46-54
3. Oates PJ (2010) Aldose reductase inhibitors and diabetic kidney disease. Curr Opin Investig Drugs 11:402-417
4. Hwang YC, Kaneko M, Bakr S et al (2004) Central role for aldose reductase pathway in myocardial ischemic injury. FASEB J 18:1192-1199
5. Yagihashi S, Mizukami H, Ogasawara S et al (2010) The role of the polyol pathway in acute kidney injury caused by hindlimb ischaemia in mice. J Pathol 220:530-541
6. Cao D, Fan ST, Chung SS (1998) Identification and characterization of a novel human aldose reductase-like gene. J Biol Chem 273:11429-11435
7. Fukumoto S, Yamauchi N, Moriguchi H et al (2005) Overexpression of the aldo-keto reductase family protein akr1b10 is highly correlated with smokers' non-small cell lung carcinomas. Clin Cancer Res 11:1776-1785
8. Yoshitake H, Takahashi M, Ishikawa H et al (2007) Aldo-keto reductase family 1, member b10 in uterine carcinomas: a potential risk factor of recurrence after surgical therapy in cervical cancer. Int J Gynecol Cancer 17:1300-1306
9. Heringlake S, Hofdmann M, Fiebeler A et al (2010) Identification and expression analysis of the aldo-ketoreductase1-B10 gene in primary malignant liver tumours. J Hepatol 52:220-227
10. Wang C, Yan R, Luo D et al (2009) Aldo-keto reductase family 1 member B10 promotes cell survival by regulating lipid synthesis and eliminating carbonyls. J Biol Chem 284:26742-26748
11. Martin HJ, Breyer-Pfaff U, Wsol V et al (2006) Purification and characterization of akr1b10 from human liver: role in carbonyl reduction of xenobiotics. Drug Metab Dispos 34:464-470
12. Koie T, Yamamoto H, Okamoto A et al (2009) Feasibility and efficacy of gemcitabine and carboplatin neoadjuvant chemotherapy in muscle-invasive bladder cancer. J Clin Oncol 27(suppl):e16100
13. Calvert AH, Newell DR, Gumbrell LA et al (1989) Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol 7:1748-1756
14. Langer S, Kokozidou M, Heiss C et al (2010) Chronic kidney disease aggravates arteriovenous fistula damage in rats. Kidney Int 78:1312-1321
15. Takahashi M, Hoshi A, Fujii J et al (1996) Induction of aldose reductase gene expression in LEC rats during the development of the hereditary hepatitis and hepatoma. Jpn J Cancer Res 87:337-341
16. Zeindl-Eberhart E, Jungblut PR, Otto A et al (1997) Further characterization of a rat hepatoma-derived aldose-reductase-like protein - organ distribution and modulation in vitro. Eur J Biochem 247:792-800
17. Baris D, Karagas MR, Verrill C et al (2009) A case-control study of smoking and bladder cancer risk: emergent patterns over time. J Natl Cancer Inst 101:1553-1561
18. Kurahashi N, Inoue M, Iwasaki M et al (2009) Coffee, green tea, and caffeine consumption and subsequent risk of bladder cancer in relation to smoking status: a prospective study in Japan. Cancer Sci 100(2):294-391
19. Yan R, Zu X, Ma J et al (2007) Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: implication for cancer intervention. Int J Cancer 121:2301-2306